Get Permission Sheet, Pothal, Manjhi, Dutta, and Chatterjee: Erasmus syndrome: A rare case report


Introduction

Inhalation of silica leads to multiple occupational and environmental illness. 1 Among which silicosis is most common, apart from silicosis it may manifest autoimmune disease like systemic sclerosis.2 Erasmus syndrome is a very rare progressive occupational disease caused by inhalation of crystalline silica where there is development of progressive systemic sclerosis. 3 Here we present a case of 52 years stone crusher who was misdiagnosed as tuberculosis but subsequently diagnosed as Erasmus syndrome.

Figure 1

Loss of forehead wrinkling, patchy depigmented and pigmented areas suggestive of Salt and pepper dermopathy

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/75671ea1-4888-4277-aae0-074858621634image1.png
Figure 2

Skin fixity of hands and digits with apparent clawing and patchy pigmented and hyperpigmented areas over hands

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/75671ea1-4888-4277-aae0-074858621634image2.png
Figure 3

Chest X-ray showing bilateral upper andmidzones Micronodules (left &; right)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/75671ea1-4888-4277-aae0-074858621634image3.png
Figure 4

A&B: HRCT thorax showing multiple subpleural and centrilobular nodules in bilateral upper, lower lobes and right middle lobe and progressive massive fibrosis there is also bronchial dilatation and fibrosis

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/75671ea1-4888-4277-aae0-074858621634image4.png
Figure 5

A & B: Mediastinal window of HRCT chest showing irregular pleural thickening with calcification, calcified right hilar and mediastinal lymphadenopathy

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/75671ea1-4888-4277-aae0-074858621634image5.png

Case Presentation

A 52 years old male patient presented with increasing breathlessness on physical exertion, and tightening of skin over the fingers and forearms (for last 12 months), sporadic bluish discoloration of fingers on exposure to cold (suggestive of Raynaud’s phenomenon), as well as low grade irregular fever and unproductive cough (for last eight months). There was no history of arthralgia, chest pain, dysphagia, haemoptysis, and loss of appetite or weight loss or reflux disease. He was non-smoker and had no history of hypertension or diabetes mellitus. He worked as a stone crusher for nearly 22 years and was forced to leave that job nine months back due to excessive breathlessness. Treatment history revealed his treatment with anti-tubercular therapy four times at various local hospitals but he never completed a course due to gastrointestinal intolerance. Other than that, there was no other significant drug history. He had no family history of similar complaints.

General examination revealed no clubbing, pallor or cyanosis. There was loss of wrinkling over forehead, facial dry skin with irregular hypopigmentation and depigmentation suggestive of salt and pepper dermopathy (Figure 1). Digital examination revealed apparent clawing of fingers due to skin fixity. There was also thickening of skin over fingers and forearm and hypopigmented patchy areas over the dorsum of his hands (Figure 2). Joints of the upper and lower extremities were non-tender. There was no calcinosis cutis. Examination of respiratory system revealed vesicular breath sounds both side and inspiratory coarse crepitation over bilateral infraclavicular, mammary, suprascapular and infrascapular areas. No abnormalities were detected on cardiac and abdominal examinations.

Investigations

Full blood count, liver, renal function tests, serum electrolytes and urinalysis were within normal limits. Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) serology was negative. Chest X-ray showed bilateral upper and midzones micronodules (Red arrows, Figure 3). High resolution Computed Tomography (HRCT) of the thorax showed multiple sub-pleural and centri-lobular nodules in bilateral upper, lower lobes and right middle lobe, conglomerated nodular opacities consistent with progressive massive fibrosis (PMF) (Red arrows in Figure 4a&b). Furthermore, there was pleural thickening and calcification, bronchial dilatation and fibrosis, calcified right hilar and mediastinal lymphadenopathy (Red arrows in Figure 5a&b). Spirometry revealed severe restrictive abnormality [Forced vital capacity (FVC)- 43%, Forced expiratory volume in the first second (FEV1)- 51% and FEV1/FVC 86%]. Sputum and Bronchoalveolar lavage (BAL) fluid were negative for Ziehl-neelsen stain (AFB). Fibreoptic bronchoscopy revealed normal tracheobronchial tree. BAL fluid gene xpert cartridge- based nucleic acid amplification test (CBNAAT) for mycobacterium tuberculosis and rifampicin (MTB/Rif) was not detected. BAL fluid cytology showed increased Polymorphonuclear (PMN), Lymphocyte and alveolar macrophages. Antinuclear antibodies (ANA) by Hep-2 method was found to be positive in high titres (1:640). In addition, nuclear speckled pattern and Anti Scl-70 antibody were also positive (3+). However, serum C reactive protein (CRP) (CRP 4mg/dl) and rheumatoid factor was negative. Echocardiography was normal and without any pulmonary arterial hypertension.

Diagnosis

Based on the presence of clinical features, Raynaud’s phenomenon, sclerodactyly, skin tightening over the face and extremities, typical salt and pepper dermopathy, positive Anti Scl-70 antibody, a diagnosis of systemic sclerosis was made asper American college of rheumatology (ACR)/European league against rheumatism (EULAR) criteria for systemic sclerosis. Furthermore, chronic silicosis was diagnosed based on prolonged occupational exposure to silica (for 22 years) due to stone crushing, absence of any chronic drugs exposure or similar family history, presence of micronodules, progressive massive fibrosis (PMF), calcified mediastinal lymphadenopathy and fibrosis in chest radiology (HRCT chest). Finally, an etiological diagnosis of Erasmus syndrome (cutaneous systemic sclerosis associated with silica exposure) was proposed because of association of silicosis and systemic sclerosis.

Treatment and follow-up

Treatment was initiated with tapering dose of prednisolone (40 mg/day based on body weight 48 kg), cyclophosphamide (1 g/month for 6 months) and Nifedipine (started with 20 mg/day and with a plan to increase up to 120 mg/day over next 6 months and to continue lifelong). He was also advised to evade exposure to cold strictly and to attend follow-up clinics on a regular basis.

Discussion

Systemic sclerosis is a multisystem autoimmune disorder of idiopathic aetiology manifested vasculopathic changes, and diffuse tissue fibrosis in multiple organs such as lung, heart, kidney and gastrointestinal tract, as well as skin. It is predominantly found in females. However, males have a more severe expression of disease and higher mortality. 1 It may be caused by environmental and occupational exposures to vinyl chloride, organic solvent, and seldom by silica.

Silicosis is a type of pneumoconiosis. It is an occupational disease characterised by irreversible lung fibrosis because of crystalline silica inhalation, retention, and pulmonary reaction among workers in mining, quarrying, masonry and sand blasting sectors. Silicosis is frequently linked with tuberculosis (silico-tuberculosis), lung carcinoma and occasionally related with systemic sclerosis (silica associated systemic sclerosis -SA-SS), systemic lupus erythematosus and rheumatoid arthritis. 2

Exposure to silica affects both humoral and cellular immunity, hypergammaglobulinemia and results in increases in antinuclear antibody and positive rheumatoid factor, as well as T-helper and T-suppressor lymphocytes.3 Moreover, continual exposure to silica results in changes in soluble interleukin-2 (IL-2) receptors. Elevated lymphokines can either trigger collagen synthesis directly or prompt other cells (like monocytes or mast cells) to release factors that further stimulate collagen production in fibroblasts. This assertion is corroborated by heightened levels of soluble IL-2 receptors observed in individuals with systemic sclerosis. It is postulated that silica could activate monocyte to release fibroblast proliferative factors (such as cytokine IL-1, 6, and TNF alpha), which in turn promotes collagen production, resulting in cutaneous sclerosis, vascular occlusion, and pulmonary fibrosis.. 4

In 1914 Bramwel first observed the association of previous exposure to silica and later development of systemic sclerosis.5 Subsequently, Erasmus in 1957 demonstrated a notable occurrence of progressive systemic sclerosis (PSS) among gold miners exposed to dust containing a significant proportion of free silica (±30%). Later on, Devulder et al. in 1977 explored the link between silica and systemic sclerosis, suggesting the term "Erasmus syndrome" to describe the concurrent presence of silicosis and PSS.6

In India, the initial instance of "Erasmus syndrome" (silicosis-induced systemic sclerosis) was documented by Khanna et al. in 1997.7 Following that, three additional cases were also documented. 8, 9, 10

Conclusion

Erasmus syndrome is a sporadic progressive disease caused by inhalation of crystalline silica, where there is development of progressive systemic sclerosis, which leads to progressive dyspnoea and multiple symptoms. There might be associated interstitial lung disease or severe restrictive lung disease over silicotic lung. Sometimes, pulmonary hypertension could be developed which can complicate the morbidity of silicosis. Therefore, while dealing with the systemic sclerosis occupational exposure to silica to be searched and while dealing with silicosis features of systemic sclerosis to be looked for as well as serological testing must be ordered to detect early Erasmus syndrome.

Declaration of Patient Consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Source of Funding

None.

Conflicts of Interest

There are no conflicts of interest.

Acknowledgments

Contributors: CKS, SP: clinical care of the patient. SC, CKS: compiling data and interpretation, figures, manuscript writing. PD, RM &; CKS: revision and final approval of manuscript. Final approval of the version published has been agreed by SP, RM, PD, SC & CKS.

References

1 

M Hughes JD Pauling L Armstrong-James CP Denton P Galdas C Flurey Gender-related differences in systemic sclerosisAutoimmun Rev202019410249410.1016/j.autrev.2020.102494

2 

AC Koeger T Lang D Alcaix B Milleron S Rozenberg P Chaibi Silica -associated connective tissue disease. A study of 24 casesMedicine (Baltimore)199574522137

3 

S Rauniyar B Thapa P Gupta R Subedi B Baral Erasmus syndrome: A rare case report of silicosis and systemic sclerosisClin Case Rep2023119793510.1002/ccr3.7935

4 

S Y Diaz M Moran P Unamuno M Armiyo Silica and Trichloroethylene induced Progressive Systemic SclerosisDermatology1992184298102

5 

B Bramwell Diffuse scleroderma: its frequency; its occurrence in stonemasons, its treatment by fibrinolysin, elevation of temperature do to fibrinolysin injectionsEdinburgh Med J1914125387401

6 

B Devulder B Plouvier J C Martin L Lenoir [The association: scleroderma-silicosis or Erasmus' syndrome (author's transl)]Nouv Presse Med197763228779

7 

N Khanna P Dsouza A Sud RK Pandhi Systemic sclerosis in a stone cutterIndian J Dermatol Venereol Leprol19976321113

8 

M Bainara M Arya Silica associated systemic sclerosis-an uncommon case reportInt J Res Med20132199202

9 

J Ganguly A Kumar S K Samanta R Mitra S Kundu Erasmus syndrome: A case report of silicosis induce scleroderma in a 26-year-old maleOman Med J2013285e05810.5001/omj.2013.110

10 

A Goyal K Madan N Singh Erasmus Syndrome with pulmonary tuberculosisBMJ Case Rep2013bcr201301044310.1136/bcr-2013-010443



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 07-10-2024

Accepted : 18-04-2024


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijirm.2024.008


Article Metrics






Article Access statistics

Viewed: 641

PDF Downloaded: 721



Medical Abbreviation List